Official Says Vietnam Must Bolster Firms Ancillary To Drug Making
This article was originally published in PharmAsia News
Vietnam's deputy prime minister said his country must shore up companies that pharmaceutical makers need if the drug firms are to grow. He identified drug-price management, hospital drug management and increased supplies of drugs throughout the country as among industry needs. Vietnam still imports about half the active ingredients needed for drug making and two-thirds of its pharmaceutical firms are under pressure to comply with good manufacturing practices by the end of June. (Click here for more
You may also be interested in...
A new report focused on the European market says that winning trust is the key to taking AI adoption to the next stage. That approach was praised by MedTech Europe CEO Serge Bernasconi.
As the transition period following the UK’s withdrawal from the European Union draws to a close, cosmetics industry stakeholders are following final trade negotiations while readying themselves for new regulatory complexities.
Purdue’s opioid settlement is making headlines for the size of the financial penalty. But the plan to re-imagine Purdue as a ‘public benefit company’ could have far-reaching significance for the industry – if it ever gets off the ground.